GlassScriptPhysician profile
Ton Q Ho
NPI 1295179182
$2,344.97
in general payments reported to CMS, 2019-2025
20 companies · $457 in 2025
The $457 reported for 2025 was more than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $206 · 2020: $33.74 · 2021: $12.56 · 2022: $1,262 · 2023: $141 · 2024: $233 · 2025: $457.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $830.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Fortis Surgical, LLC | $1,234.35 | 2022 | |
| Stryker Corporation | $257.40 | 2020-2025 | Augment Injectable, Prostep Mica, Fuseforce |
| Organogenesis INC. | $138.93 | 2024-2025 | Apligraf, Cygnus Dual |
| Biowound Solutions, INC. | $132.86 | 2025 | Bio-Connekt |
| Smith+Nephew, INC. | $71.27 | 2019-2025 | Collagenase Santyl, Iodosorb Ointment 40g USA |
| Averitas Pharma INC. | $69.79 | 2023-2024 | Qutenza |
| Horizon Therapeutics Plc | $58.43 | 2019 | |
| Integra Lifesciences Corporation | $56.22 | 2023-2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Biopro, INC. | $52.45 | 2019 | |
| Acumed LLC | $40.24 | 2024 | Acumed, Osteomed |
| Melinta Therapeutics, LLC | $31.87 | 2019 | |
| Abbott Laboratories | $31.50 | 2025 | Eterna |
| Ossio INC | $30.10 | 2023 | |
| Reapplix INC. | $27.70 | 2025 | 3c Patch Kit - Box |
| Merck Sharp & Dohme LLC | $26.99 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $21.14 | 2023 | Va-Lcp |
| Sebela Pharmaceuticals INC. | $19.59 | 2019 | |
| Ibsa Pharma INC. | $15.80 | 2023 | Tirosint, Licart |
| Medtronic, INC. | $14.44 | 2024 | Intellis Adaptivestim |
| Kowa Pharmaceuticals America, INC. | $13.90 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ton Ho listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.